Larvol Delta - RealWorld-Burden-of-Infections-in-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma-Treated-with-Elranatamab-in-Japan-Findings-from-the-SUMMIT-Study

Elrexfio (elranatamab-bcmm) - Pfizer

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826743&rnd=0.7043958

Satoshi Yoshihara, MD, PhD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next